Search

Your search keyword '"Migraine -- Prevention"' showing total 351 results
Start Over Descriptor "Migraine -- Prevention"
351 results on '"Migraine -- Prevention"'

151. Migraine Awareness Month

Subjects
Health care industry -- Marketing, Migraine -- Prevention, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Display packs for Migraine Awareness Month, which runs throughout September, are being distributed by the Migraine Awareness Trust. The principal message of the campaign is that one in six of [...]

Published
2002

152. Depakote ER

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Depakote ER (Medication) -- Product introduction, Migraine -- Prevention, Pharmaceutical industry -- Product introduction, Pharmaceuticals and cosmetics industries, Product introduction, Prevention
Abstract

A new strength of the divalproex sodium extended release tablets (Depakote ER, Abbott Laboratories), 250 mg, has been approved for migraine headache prevention. Previously, the drug was available in a [...]

Published
2002

153. Study takes a deeper look into migraine prevention

Subjects
Migraine -- Prevention, News, opinion and commentary, Sports and fitness, University of Iowa
Abstract

A new study from the University of Iowa and the Cincinnati Children's Hospital looks into how effective medicine is in preventing migraines in children. By Kayli Reese kayli-reese@uiowa.edu Migraine medicine [...]

Published
2016

155. Alder (ALDR) Stock Spikes on Successful Migraine Prevention Study

Subjects
Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Stocks, Pharmaceutical industry, Biological products, Migraine -- Prevention, Business
Abstract

Byline: Rachel Graf To view this article on the web, click here: http://www.thestreet.com/story/13509026/1/alder-aldr-stock-spikes-on-successful-migraine-prevention-study.html NEW YORK (TheStreet (http://www.thestreet.com)) -- Alder BioPharmaceuticals (ALDR) stock is skyrocketing by 47.96% to $25.42 on heavy [...]

Published
2016

157. Migraine Headaches

Subjects
Depakote ER (Medication) -- Dosage and administration, Pharmaceutical industry -- Product information, Divalproex -- Dosage and administration, Migraine -- Prevention
Abstract

Depakote ER (divalproex sodium extended-release tablets) offers once-daily dosing for the prevention of migraine headaches in [...]

Published
2001

158. Tiazac for migraine

Author

Berman, Leo H.

Subjects
Off-label prescribing -- Evaluation, Migraine -- Prevention, Psychotropic drugs, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health, Tiazac (Medication) -- Evaluation -- Product/service Evaluations
Abstract

One reader passed along some information about migraine treatment (see PU February 2001): 'I would like to call attention to the prophylactic use of Tiazac, calcium blocker, which has resulted [...]

Published
2001

159. Many Migraines Can Be Prevented With Treatments, But Few Use Them

Subjects
Migraine -- Prevention, General interest
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=155575937 Millions of Americans suffer from migraines, and some of those headaches are so disabling that people are forced to stay home from [...]

Published
2012

160. More medications moving into migraine marketplace

Author

Levy, Sandra

Subjects
McNeil Consumer Products Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Migraine -- Prevention
Abstract

The 30 million Americans who experience migraine headaches have two new--well, sort of new--over-the-counter medications to reach for. The products contain the same ingredients as the manufacturers' original offerings; what's [...]

Published
2000

161. Taking a New Shot at Migraine Pain

Author

Aschwanden, Christie, Cederborg, Julie, Freinkel, Susan, Giri, Priya, Krieger, Elizabeth B., Motte, Paula, and Wong, Kimberly

Subjects
Botox (Medication) -- Health aspects, Migraine -- Prevention, Botulinum toxin -- Health aspects
Published
1999

162. Say No to PAIN the Way the Experts Do!

Author

EVANS, JULIE A. and DAVIS, LORI

Subjects
Headache -- Care and treatment, Arthritis -- Care and treatment, Pain -- Care and treatment, Backache -- Care and treatment, Myalgia -- Care and treatment, Analgesia -- Innovations, Migraine -- Prevention
Abstract

Here's how the pros put an end to the ache Ouch! If you're lucky, you only say that occasionally--maybe when you clunk your head getting out of the car or [...]

Published
1999

163. Hands-On Migraine Relief

Author

O'Donnell, Sara Altshul

Subjects
Migraine -- Prevention, Massage -- Health aspects
Abstract

Massage reduces pain, improves sleep If you're one of the millions of Americans who cope regularly with migraines, here's hope. A small study (26 people) conducted by the Touch Research [...]

Published
1999

164. 'I Thought It Was a Long Shot. I Was Wrong.'

Author

Mooney, Linda

Subjects
Migraine -- Prevention, Alternative medicine -- Personal narratives
Abstract

When doctors failed to help, Oz Garcia vowed to find a cure for his raging migraines Life was good. It was 1972, and I was a young photographer starting a [...]

Published
1999

166. Upsher-Smith Enhances Website for Qudexy XR Migraine Prevention Medicine

Subjects
Web sites (World Wide Web), Prescriptions (Drugs), Migraine -- Prevention, Company Web site/Web page, Chemistry, Qudexy XR (Medication)
Abstract

M2 PHARMA-August 22, 2017-Upsher-Smith Enhances Website for Qudexy XR Migraine Prevention Medicine (C)2017 M2 COMMUNICATIONS - US-based Upsher-Smith Laboratories, LLC has launched its enhanced website for Qudexy XR (topiramate) Extended-Release [...]

Published
2017

169. US FDA Accepts Biologics License Application for Aimovig Investigative Migraine-Specific Preventive Therapy

Subjects
United States. Food and Drug Administration, Novartis AG, Preventive medicine, Monoclonal antibodies, Pharmaceutical industry, Migraine -- Prevention, Chemistry
Abstract

M2 PHARMA-July 24, 2017-US FDA Accepts Biologics License Application for Aimovig Investigative Migraine-Specific Preventive Therapy (C)2017 M2 COMMUNICATIONS - The US Food and Drug Administration (FDA) has accepted for review [...]

Published
2017

170. Novartis submits erenumab's BLA with the US FDA for review for the prevention of migraine

Subjects
United States. Food and Drug Administration, Novartis AG, Health care industry, Pharmaceutical industry, Migraine -- Prevention, Health care industry, Chemistry
Abstract

M2 PHARMA-July 21, 2017-Novartis submits erenumab's BLA with the US FDA for review for the prevention of migraine (C)2017 M2 COMMUNICATIONS Healthcare solutions company Novartis said on Thursday that the [...]

Published
2017

171. Novartis submits erenumab's BLA with the US FDA for review for the prevention of migraine

Subjects
United States. Food and Drug Administration, Novartis AG, Health care industry, Pharmaceutical industry, Migraine -- Prevention, Health care industry, Business
Abstract

M2 EQUITYBITES-July 21, 2017-Novartis submits erenumab's BLA with the US FDA for review for the prevention of migraine (C)2017 M2 COMMUNICATIONS http://www.m2.com Healthcare solutions company Novartis said on Thursday that [...]

Published
2017

172. Melatonin can help with migraine prevention

Author

Hudson, Tori

Subjects
Melatonin -- Health aspects, Migraine -- Prevention, Health
Abstract

Migraines are chronic and debilitating, affect 12% to 20% of the world's population, and are more common in women. Women account for about three-quarters of the 28 million Americans who [...]

Published
2016

173. Acupuncture, real and fake, helps prevent migraines: researchers

Subjects
Migraine -- Prevention, Acupuncture, General interest, News, opinion and commentary
Abstract

Acupuncture helps to prevent headaches including migraines but faked procedures, in which needles are incorrectly inserted, can be equally effective, two reviews suggest. In Wednesday's Cochrane Review journal, researchers in [...]

Published
2009

174. Anti-CGRP agent prevented episodic migraines long term

Author

London, Susan

Subjects
Antibodies, Migraine -- Prevention, Health, American Academy of Neurology
Abstract

AT THE AAN 2016 ANNUAL MEETING VANCOUVER--An investigational antibody that targets the calcitonin gene-related peptide (CGRP) receptor may be efficacious and safe in the longer term for preventing episodic migraine, [...]

Published
2016

177. Migraine

Author

Galea Debono, Anthony

Subjects
Migraine -- Pathophysiology, Migraine -- Prevention, Migraine -- Treatment, Migraine -- Diagnosis
Abstract

Migraine is perhaps one of the commonest ailments afflicting mankind. Two of the most important studies about the prevalence of migraine are the American Migraine Studies 1 and 2. The first study was carried out in 1989 and the second in 1999. These studies showed that the prevalence of migraine remained the same overall. In 1989, 5,7% of the male population had migraine, while in 1999, the figure was 6,5%. The prevalence rates for women were 17,6% in 1989 and 18,2% in 1999. The diagnosis of migraine was based on the criteria established by the International Headache Society (IHS)., peer-reviewed

Published
2006

178. Where does it hurt? Understanding and dealing with pain

Author

Gorman, Gail

Subjects
Fibromyalgia -- Risk factors, Music -- Influence, Music -- Psychological aspects, Migraine -- Prevention, Migraine -- Care and treatment, Migraine -- Psychological aspects, Chronic pain -- Evaluation, Acetaminophen -- Evaluation, Anti-inflammatory drugs -- Evaluation, Opioids -- Evaluation, Pain -- Care and treatment, Pain -- Evaluation
Abstract

An astounding 57.2 percent of adults in the United States report experiencing chronic or recurrent pain. (1) Worse yet, nine out of ten Americans report that they regularly have some […]

Published
2005

179. Standardized butterbur extract: herbal approach to migraine prophylaxis

Author

Brown, Donald J.

Subjects
Petasite -- Health aspects, Migraine -- Prevention, Medicinal plants -- Evaluation, Health, Prevention, Evaluation, Health aspects
Abstract

The development of a standardized extract of the rhizome of butterbur (Petasites hybridus) has led to a new clinical approach to the management of migraine headaches. Two clinical trials with [...]

Published
2002

180. Study: Migraine-prevention wearable helps brain metabolic activity return to normal

Author

Lawrence, Stacy

Subjects
Brain, Migraine -- Prevention, Science and technology
Abstract

Byline: Stacy Lawrence Belgium-based Cefaly Technologies already secured FDA approval for its headband-like device that stimulates the trigeminal nerve to reduce the frequency and intensity of migraines in March 2014. [...]

Published
2015

182. Migraines can be managed with preventive therapies: weekly headaches might call for prevention

Author

Zablocki, Elaine

Subjects
Medicine, Preventive, Migraine -- Prevention, Preventive health services, Business, Health care industry
Abstract

Migraine headaches became a political issue a few months ago, when the news spread that presidential candidate Michelle Bachmann experiences severe migraines, which have occasionally led to hospitalization. Bachmann released [...]

Published
2011

183. Prevention of migraine

Author

Dodick, David W.

Subjects
Adrenergic beta blockers -- Usage, Adrenergic beta blockers -- Health aspects, Migraine -- Drug therapy, Migraine -- Patient outcomes, Migraine -- Prevention
Published
2010

184. The Claim: To prevent migraines, drink more water

Author

O'Connor, Anahad

Subjects
Dehydration (Physiology) -- Health aspects -- Prevention, Migraine -- Prevention, Water -- Health aspects, General interest, News, opinion and commentary
Abstract

THE FACTS For migraine sufferers, summer can be a perilous time of year. Oppressive heat and spikes in temperature have long been thought to precipitate attacks in people prone to [...]

Published
2011

185. Low-dose riboflavin may prevent migraines

Author

Gaby, Alan R.

Subjects
Vitamin B2 -- Dosage and administration, Migraine -- Prevention
Abstract

Forty-nine patients with migraines were randomly assigned to receive, in double-blind fashion, daily treatment with 1) a combination of riboflavin 400 mg, magnesium 300 mg, and feverfew 100 mg or [...]

Published
2007

188. Migraine Prevention Device CEFALY Now Available for US Purchase and Delivery

Subjects
United States. Food and Drug Administration, Migraine -- Prevention, Business, News, opinion and commentary
Abstract

U.S. migraine patients with a prescription may now buy innovative medical device NEW YORK, April 23, 2014 /PRNewswire/ -- After much anticipation, CEFALY Technology announced today that the Cefaly medical [...]

Published
2014

189. Data From Proof-of-Concept Clinical Trial of ALD403, a Monoclonal Antibody Against CGRP for the Prevention of Migraine, to be Presented at American Academy of Neurology Meeting

Subjects
Biological products -- Product development, Migraine -- Prevention, Clinical trials, Monoclonal antibodies, Banking, finance and accounting industries, Business, University of California
Abstract

BOTHELL, Apr 23, 2014 (GLOBE NEWSWIRE via COMTEX) -- Alder Biopharmaceuticals Inc. today announced that Dr. Peter J. Goadsby, M.D., Ph.D., director, NIHR-Wellcome Trust Clinical Research Facility, King's College London [...]

Published
2014

190. First-of-its-kind migraine prevention device wins FDA approval

Author

Hollmer, Mark

Subjects
Migraine -- Prevention, Science and technology
Abstract

Byline: Mark Hollmer In a first, the FDA has approved a medical device designed to prevent http://www.fiercemedicaldevices.com/tags/migraine headaches. Designed by Cefaly Technology in Belgium, the product, dubbed Cefaly, is a [...]

Published
2014

192. World's first migraine-prevention device gets US FDA nod

Subjects
United States. Food and Drug Administration, Migraine -- Prevention, Business, international
Abstract

The US Food and Drug Administration on Tuesday allowed marketing of 'Cefaly', the first device allowed by it as a preventative treatment for migraine headaches. This is also the first [...]

Published
2014

193. United States : FDA allows marketing of first medical device to prevent migraine headaches

Subjects
United States. Food and Drug Administration, Medical equipment -- Marketing, Migraine -- Prevention, Physiological apparatus -- Marketing, Marketing, Company marketing practices, Business, international
Abstract

Today, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) [...]

Published
2014

194. U.S. FDA approves first device to prevent migraine headaches

Subjects
United States. Food and Drug Administration, Migraine -- Prevention, Business, general, General interest, News, opinion and commentary
Abstract

WASHINGTON, Mar 11, 2014 (Xinhua via COMTEX) -- The U.S. Food and Drug Administration (FDA) said Tuesday it has approved the marketing of a medical device as a preventative treatment [...]

Published
2014

195. Doctor's orders: getting the FDA to give your medical invention the thumbs up can be a challenge, so follow this prescription for approval

Author

Debelak, Don

Subjects
Migraine -- Prevention, Entrepreneurship -- Methods, Businesspeople -- Methods, Business, general, Business, Prevention, Methods
Abstract

THE ENTREPRENEUR: Dr. Jim B0yd, 46, a dentist in San Diego and founder of NTI-TSS Inc. (www.nti-tss.com) in Mishawaka, Indiana, maker of the NTI PRODUCT DESCRIPTION: FDA-approved for migraine prevention, [...]

Published
2005

196. Seeking balance: the alternative of Chinese medicine: tea brewed from a carefully formulated mixture of herbs plays an important role in Tradional Chinese Medicine

Author

Hoffman, Kayla

Subjects
Medicine, Chinese -- Health aspects, Migraine -- Care and treatment, Migraine -- Prevention
Abstract

Migraines are a curse that I've dealt with since adolescence. Despite healthy eating, regular exercise and meditation, I'd regularly end up bedridden in a dark, silent room for up to […]

Published
2004

197. Topiramate for migraine prevention

Subjects
Anticonvulsants -- Dosage and administration, Topiramate -- Dosage and administration, Migraine -- Prevention, Health
Abstract

Source: Brandes JL, et al. JAMA. 2004;291(8):965-973. SOME PATIENTS REMAIN DISSATISFIED with or intolerant of available migraine treatments. Early studies have found that topiramate (TOP), an antiepileptic agent, is efficacious [...]

Published
2004

198. Topiramate for migraine prevention

Author

Kuritzky, Louis

Subjects
Anticonvulsants -- Dosage and administration, Topiramate -- Dosage and administration, Migraine -- Prevention, Health
Abstract

Source: Brandes JL, et al. JAMA. 2004;291(8):965-973. SOME PATIENTS REMAIN DISSATISFIED migraine treatments. Early studies have found that topiramate (TOP), an antiepileptic agent, is efficacious for migraine prevention. Although there [...]

Published
2004

199. Topiramate for migraine prevention

Subjects
Anticonvulsants -- Health aspects, Anticonvulsants -- Research, Headache -- Prevention, Topiramate -- Health aspects, Topiramate -- Research, Migraine -- Prevention, Health
Abstract

Source: Brandes JL, et al. JAMA. 2004;291(8):965-973. SOME PATIENTS REMAIN DISSATISFIED with or intolerant of available migraine treatments. Early studies have found that topiramate (TOP), an antiepileptic agent, is efficacious [...]

Published
2004

200. Stop your next headache: preventing a headache is more effective than trying to stop one once it starts. Here's how to do it, no matter what kind of head pain you have. (Health Check)

Author

Noe, Camille

Subjects
Migraine -- Causes of, Migraine -- Prevention, Migraine -- Care and treatment, Migraine -- Diagnosis, Headache -- Care and treatment, Headache -- Prevention, Headache -- Causes of, Headache -- Diagnosis, Fashion and beauty, Women's issues/gender studies
Abstract

If you have headaches twice a week or more When you feel a dull ache or band-like pain, or have soreness in your temples, you have what most experts call [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results